Live Nasdaq Composite: Markets Take Breather After Impressive Q2 Showing on Easing Oil Outlook
Q2 25 EPS
$0.07
BEAT +566.67%
Est. $-0.02
Q2 25 Revenue
$1.02B
BEAT +5.70%
Est. $960.5M
vs S&P Since Q2 25
+32.2%
BEATING MARKET
ALHC +49.9% vs S&P +17.7%
Market Reaction
Did ALHC Beat Earnings? Q2 2025 Results
Alignment Healthcare delivered a breakout second quarter, crossing the billion-dollar revenue mark for the first time and swinging decisively to profitability. The value-based Medicare Advantage insurer posted revenue of $1.02 billion, beating the $9… Read more Alignment Healthcare delivered a breakout second quarter, crossing the billion-dollar revenue mark for the first time and swinging decisively to profitability. The value-based Medicare Advantage insurer posted revenue of $1.02 billion, beating the $960.51 million consensus by 5.70% and marking a 49.0% jump from a year earlier, while EPS of $0.07 cleared the $-0.02 analyst estimate by 566.67%, reversing a loss of $0.13 in the prior-year period. The driving force behind the quarter was a 27.8% surge in health plan membership to roughly 223,700 members, which scaled premium revenue while an improved medical benefits ratio of 86.7% demonstrated that cost discipline kept pace with growth. Adjusted EBITDA soared to $45.91 million from just $6.03 million a year ago, underscoring the operating leverage embedded in the model. Looking ahead, management raised full-year 2025 revenue guidance to $3.89 billion to $3.91 billion and lifted adjusted EBITDA guidance to $69 million to $83 million, signaling sustained confidence even as peers in the Medicare Advantage space continue to navigate a pressured reimbursement environment.
Key Takeaways
- • 27.8% year-over-year health plan membership growth to approximately 223,700 members
- • 49.0% year-over-year revenue growth driven by membership expansion
- • Medical benefits ratio improvement to 86.7%
- • Swing to GAAP profitability with income from operations of $22.7 million versus prior-year loss of $18.4 million
- • Adjusted EBITDA surged to $45.9 million from $6.0 million year over year
ALHC YoY Financials
Q2 2025 vs Q2 2024, source: SEC Filings
ALHC Revenue by Segment
With YoY comparisons, source: SEC Filings
“In today's Medicare Advantage environment, Alignment Healthcare's second quarter performance proves that strong financial results and high-quality care can go hand in hand – with the right model.”
— John Kao, Q2 2025 Earnings Press Release
ALHC Earnings Trends
ALHC vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
ALHC EPS Trend
Earnings per share: estimate vs actual
ALHC Revenue Trend
Quarterly revenue: estimate vs actual
ALHC Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 MISS | $0.09 | $0.05 | -42.86% | $1.24B | +1.42% |
| Q4 25 BEAT FY | $-0.08 | $-0.05 | +37.50% | $1.01B | +0.94% |
| FY Full Year | $0.23 | $0.00 | -100.00% | $3.95B | +0.24% |
| Q3 25 BEAT | $-0.01 | $0.02 | +300.00% | $993.7M | +1.26% |
| Q2 25 BEAT | $-0.02 | $0.07 | +566.67% | $1.02B | +5.70% |
| Q1 25 BEAT | $-0.07 | $-0.05 | +30.56% | $926.9M | +4.35% |